Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,950
Closed -$1.1M 108
2021
Q3
$1.1M Buy
+14,950
New +$1.12M 0.16% 57
2015
Q2
Sell
-23,841
Closed -$787K 90
2015
Q1
$787K Sell
23,841
-1,616
-6% -$49.6K 0.26% 48
2014
Q4
$681K Buy
25,457
+300
+1% +$7.74K 0.22% 52
2014
Q3
$612K Buy
25,157
+1,944
+8% +$49.1K 0.2% 56
2014
Q2
$588K Sell
23,213
-1,535
-6% -$35.9K 0.19% 51
2014
Q1
$532K Sell
24,748
-5,275
-18% -$114K 0.16% 55
2013
Q4
$671K Sell
30,023
-8,875
-23% -$196K 0.2% 45
2013
Q3
$803K Sell
38,898
-2,288
-6% -$48.7K 0.25% 42
2013
Q2
$795K Buy
+41,186
New +$860K 0.29% 38

Other funds holding HOLX

Gagnon Securities's HOLX Position: Q4 2021 in Review

Gagnon Securities sold out of Hologic (HOLX) in Q4 2021, closing a stake of 14,950 shares — an estimated $1.1M sold.

Gagnon Securities first reported a position in HOLX in Q2 2013 and held it in 9 quarters. The position peaked at $1.1M in Q3 2021. 679 funds tracked by Wall St. Rank hold HOLX as of Q4 2021.

  • Gagnon Securities reported no remaining Hologic position as of Q4 2021 after selling out during the quarter.
  • Gagnon Securities sold 14,950 Hologic shares in Q4 2021, an estimated $1.1M.
  • Gagnon Securities first reported a position in Hologic in Q2 2013 and held it in 9 quarters.
  • Gagnon Securities's Hologic position peaked at $1.1M in Q3 2021.
  • 679 funds tracked by Wall St. Rank held Hologic as of Q4 2021.

Based on Gagnon Securities's 13F filing for Q4 2021, filed 8 Feb 2022.